# Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal

> **NCT04939623** · PHASE2 · RECRUITING · sponsor: **University of Calgary** · enrollment: 40 (estimated)

## Conditions studied

- Chronic Pain
- Drug Dependence of Morphine Type
- Symptom, Withdrawal

## Interventions

- **DRUG:** Probenecid

## Key facts

- **NCT ID:** NCT04939623
- **Lead sponsor:** University of Calgary
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2026-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04939623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04939623, "Novel Use of Probenecid to Alleviate Symptoms of Opioid Withdrawal". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04939623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*